Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease

被引：0
|
作者：
Trenschel, R
Trampenau, C
Ditschkowski, M
Elmaagacli, A
Ottinger, H
Steckel, N
Biersack, H
Peceny, R
Beelen, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [1] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [2] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [3] Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
    Pidala, Joseph
    Kim, Jongphil
    Field, Teresa
    McBride, Ali
    Kharfan-Dabaja, Mohamed
    Perkins, Janelle
    Fernandez, Hugo
    Perez, Lia
    Ayala, Ernesto
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1116 - 1121
  • [4] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
  • [5] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Krejci, M
    Doubek, M
    Buehler, T
    Brychtova, Y
    Vorlicek, J
    Mayer, J
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 681 - 685
  • [6] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Marta Krejci
    Michael Doubek
    Tomas Buchler
    Yvona Brychtova
    Jiri Vorlicek
    Jiri Mayer
    Annals of Hematology, 2005, 84 : 681 - 685
  • [7] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
  • [8] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [9] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [10] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
12345